Skip to main content
Clinical Trials/CTRI/2022/10/046867
CTRI/2022/10/046867
Not yet recruiting
Phase 2

Preclinical and Clinical evaluation of the effect on oral administration of SEENTHIL KIRUTHAM along with external application of KUPPAIMENI THAILAM in the management of SIRANGU (SCABIES) in children

Dr K Gowsalya0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr K Gowsalya
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
Dr K Gowsalya

Eligibility Criteria

Inclusion Criteria

  • 1\. Nocturnal itching intense pruritis (particularly at night)
  • 2\. Burrows
  • 3\. Papules and Papulovesicles
  • 4\. Pustules
  • 5\. Lesions seen in webs of hands, wrist, ulnar aspect of forearm, elbows, axillae, foot, buttocks, palm and sole, genital area.

Exclusion Criteria

  • 1\. More than 12 years
  • 2\. Impetigo, Furunculosis
  • 3\. Seborrheic dermatitis
  • 4\. Tinea infections
  • 5\. Secondary complications due to scabies

Outcomes

Primary Outcomes

Not specified

Similar Trials